These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 16597712)

  • 1. A selective p38 alpha mitogen-activated protein kinase inhibitor reverses cartilage and bone destruction in mice with collagen-induced arthritis.
    Medicherla S; Ma JY; Mangadu R; Jiang Y; Zhao JJ; Almirez R; Kerr I; Stebbins EG; O'Young G; Kapoun AM; Luedtke G; Chakravarty S; Dugar S; Genant HK; Protter AA
    J Pharmacol Exp Ther; 2006 Jul; 318(1):132-41. PubMed ID: 16597712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of p38 mitogen-activated protein kinase prevents inflammatory bone destruction.
    Mbalaviele G; Anderson G; Jones A; De Ciechi P; Settle S; Mnich S; Thiede M; Abu-Amer Y; Portanova J; Monahan J
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1044-53. PubMed ID: 16501068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of p38 MAPK is a key step in tumor necrosis factor-mediated inflammatory bone destruction.
    Zwerina J; Hayer S; Redlich K; Bobacz K; Kollias G; Smolen JS; Schett G
    Arthritis Rheum; 2006 Feb; 54(2):463-72. PubMed ID: 16447221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. META060 inhibits osteoclastogenesis and matrix metalloproteinases in vitro and reduces bone and cartilage degradation in a mouse model of rheumatoid arthritis.
    Konda VR; Desai A; Darland G; Bland JS; Tripp ML
    Arthritis Rheum; 2010 Jun; 62(6):1683-92. PubMed ID: 20201075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-inflammatory properties of a novel N-phenyl pyridinone inhibitor of p38 mitogen-activated protein kinase: preclinical-to-clinical translation.
    Hope HR; Anderson GD; Burnette BL; Compton RP; Devraj RV; Hirsch JL; Keith RH; Li X; Mbalaviele G; Messing DM; Saabye MJ; Schindler JF; Selness SR; Stillwell LI; Webb EG; Zhang J; Monahan JB
    J Pharmacol Exp Ther; 2009 Dec; 331(3):882-95. PubMed ID: 19720877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pamapimod, a novel p38 mitogen-activated protein kinase inhibitor: preclinical analysis of efficacy and selectivity.
    Hill RJ; Dabbagh K; Phippard D; Li C; Suttmann RT; Welch M; Papp E; Song KW; Chang KC; Leaffer D; Kim YN; Roberts RT; Zabka TS; Aud D; Dal Porto J; Manning AM; Peng SL; Goldstein DM; Wong BR
    J Pharmacol Exp Ther; 2008 Dec; 327(3):610-9. PubMed ID: 18776065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of pristane-induced arthritis, a murine model of chronic disease: response to antirheumatic agents, expression of joint cytokines, and immunopathology.
    Patten C; Bush K; Rioja I; Morgan R; Wooley P; Trill J; Life P
    Arthritis Rheum; 2004 Oct; 50(10):3334-45. PubMed ID: 15476226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressive effects of PG201, an ethanol extract from herbs, on collagen-induced arthritis in mice.
    Shin SS; Jin M; Jung HJ; Kim B; Jeon H; Choi JJ; Kim JM; Cho BW; Chung SH; Lee YW; Song YW; Kim S
    Rheumatology (Oxford); 2003 May; 42(5):665-72. PubMed ID: 12709543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The alpha-isoform of p38 MAPK specifically regulates arthritic bone loss.
    Böhm C; Hayer S; Kilian A; Zaiss MM; Finger S; Hess A; Engelke K; Kollias G; Krönke G; Zwerina J; Schett G; David JP
    J Immunol; 2009 Nov; 183(9):5938-47. PubMed ID: 19828631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A p38alpha selective mitogen-activated protein kinase inhibitor prevents periodontal bone loss.
    Kirkwood KL; Li F; Rogers JE; Otremba J; Coatney DD; Kreider JM; D'Silva NJ; Chakravarty S; Dugar S; Higgins LS; Protter AA; Medicherla S
    J Pharmacol Exp Ther; 2007 Jan; 320(1):56-63. PubMed ID: 17041006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triptolide, a diterpenoid triepoxide, suppresses inflammation and cartilage destruction in collagen-induced arthritis mice.
    Lin N; Liu C; Xiao C; Jia H; Imada K; Wu H; Ito A
    Biochem Pharmacol; 2007 Jan; 73(1):136-46. PubMed ID: 17097618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological profile of AW-814141, a novel, potent, selective and orally active inhibitor of p38 MAP kinase.
    Chopra P; Kulkarni O; Gupta S; Bajpai M; Kanoje V; Banerjee M; Bansal V; Visaga S; Chatterjee M; Chaira T; Shirumalla RK; Verma AK; Dastidar SG; Sharma G; Ray A
    Int Immunopharmacol; 2010 Apr; 10(4):467-73. PubMed ID: 20093202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with anti-gamma-glutamyl transpeptidase antibody attenuates osteolysis in collagen-induced arthritis mice.
    Ishizuka Y; Moriwaki S; Kawahara-Hanaoka M; Uemura Y; Serizawa I; Miyauchi M; Shibata S; Kanaya T; Takata T; Taniguchi N; Niida S
    J Bone Miner Res; 2007 Dec; 22(12):1933-42. PubMed ID: 17680722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: a comparative study using anti-TNFalpha, anti-IL-1alpha/beta and IL-1Ra.
    Joosten LA; Helsen MM; van de Loo FA; van den Berg WB
    Arthritis Rheum; 2008 Feb; 58(2 Suppl):S110-22. PubMed ID: 18240201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. THR0921, a novel peroxisome proliferator-activated receptor gamma agonist, reduces the severity of collagen-induced arthritis.
    Tomita T; Kakiuchi Y; Tsao PS
    Arthritis Res Ther; 2006; 8(1):R7. PubMed ID: 16356194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tenosynovitis and osteoclast formation as the initial preclinical changes in a murine model of inflammatory arthritis.
    Hayer S; Redlich K; Korb A; Hermann S; Smolen J; Schett G
    Arthritis Rheum; 2007 Jan; 56(1):79-88. PubMed ID: 17195210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central role of the MEK/ERK MAP kinase pathway in a mouse model of rheumatoid arthritis: potential proinflammatory mechanisms.
    Thiel MJ; Schaefer CJ; Lesch ME; Mobley JL; Dudley DT; Tecle H; Barrett SD; Schrier DJ; Flory CM
    Arthritis Rheum; 2007 Oct; 56(10):3347-57. PubMed ID: 17907188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p38 MAPK as a potential therapeutic target for inflammatory osteolysis.
    Wei S; Siegal GP
    Adv Anat Pathol; 2007 Jan; 14(1):42-5. PubMed ID: 17198310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effects of a traditional Chinese herbal formula TBL-II on type II collagen-induced arthritis in mice.
    Shen X; Li C; Zhao H; Li S; Chen J; Kobayashi Y; Shen W
    J Ethnopharmacol; 2011 Mar; 134(2):399-405. PubMed ID: 21215307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.